603999-24-2 Usage
Uses
Used in Pharmaceutical Industry:
5-Thiazolecarboxylic acid, 2-formyl(9CI) is used as a key intermediate in the synthesis of various pharmaceuticals. Its unique structure allows for the development of new drugs with potential therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical sector, 5-Thiazolecarboxylic acid, 2-formyl(9CI) serves as a crucial component in the production of pesticides and other agrochemicals, contributing to the development of effective solutions for crop protection and management.
Used in Materials Science:
5-Thiazolecarboxylic acid, 2-formyl(9CI) may have potential applications in the field of materials science, where its chemical and physical properties can be harnessed to create novel materials with specific characteristics for various uses.
Used in Research:
As a compound with diverse chemical and physical properties, 5-Thiazolecarboxylic acid, 2-formyl(9CI) is also utilized in research settings to explore its potential in different areas of science and technology, paving the way for new discoveries and innovations.
Check Digit Verification of cas no
The CAS Registry Mumber 603999-24-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,0,3,9,9 and 9 respectively; the second part has 2 digits, 2 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 603999-24:
(8*6)+(7*0)+(6*3)+(5*9)+(4*9)+(3*9)+(2*2)+(1*4)=182
182 % 10 = 2
So 603999-24-2 is a valid CAS Registry Number.
603999-24-2Relevant articles and documents
SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF
-
Page/Page column 76, (2011/09/20)
This invention provides compounds of formula (I): wherein X1, X2, X3, R2, R4b, R1, and G have values as described in the specification, useful as inhibitors of HDAC6. The invention also provides pharmaceutical compositions comprising the compounds of the invention and methods of using the compositions in the treatment of proliferative, inflammatory, infectious, neurological or cardiovascular diseases or disorders.
CONDENSED HETEROCYCLIC COMPOUNDS AS CALCITONIN AGONISTS
-
Page/Page column 67, (2010/02/07)
The present invention relates to novel fused heterocyclic ring system compounds and methods for their use in the treatment and prevention of diseases or conditions which are related to irregular calcification.
